To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you.

New RNA from Italy Strain

Genomic RNA from the 2019-nCoV/Italy-INMI1 strain joins our portfolio of authenticated RNA prepared from Washington state and Hong Kong clinical isolates.

Explore now

Repairing Reproducibility

Reproducibility is an urgent problem. Explore what your colleagues believe is the source of the issue and what scientists can do to solve it.

Get the infographic

Ebola virus - National Institute of Allergy and Infectious Diseases (NIAID)

Enhance Virus Production

Need high-titer viral stocks? Watch our on-demand webinar to discover how STAT1 knockout cell lines can help.

Watch now

Organoid Culture Guide

Access step-by-step protocols for the thawing, culture, expansion, and cryopreservation of normal and diseased organoids.

Download now

Microbiome Panel Discussion

View a collaborative discussion featuring a panel of microbiome experts for insight on the challenges and solutions in this exciting new field.

View the discussion

Photographer holding camera pointing it forward

Submit Your Vote

Vote for your favorite photo before 11:59 PM ET on July 22, 2020. The image with the highest number of votes wins!

Vote today

Solutions

Federal

Incredible 2020

Events

Webinars

Therapeutic Development

Human mesenchymal stem cells provide a promising technology for the treatment of acute respiratory distress syndrome, pneumonia, and acute lung injury. Incorporate these cells into your research today!

Vaccine Development

Using CRISPR/Cas9 gene-editing technology, we developed STAT1 knockout cell lines capable of producing high-titer viral stocks. Explore the use of these models in your vaccine research.

Molecular-based Assays

Explore a growing collection of BSL-1 and BSL-2 COVID-19 controls, including a heat-inactivated strain and genomic RNA prepared from the 2019-nCoV/USA-WA1/2020 strain and synthetic SARS-CoV-2 RNA.

FDA/EUA Assay Development

Determine the analytical specificity of your assays by performing cross-reactivity testing with viral, fungal, and bacterial species listed in the FDA EUA. Explore our extensive portfolio.

Primary cells

Choose from our extensive catalog of primary cells from normal and diseased lung tissue. Our collection includes airway epithelial cells, smooth muscle cells, and fibroblasts as well as supporting media and growth kits.

Immune cells

Study the interactions between SARS-CoV-2 and the immune system with human PBMCs, luciferase-labeled monocytes, NK cells, helper T cells, B cells, and cytotoxic T cells from ATCC!

ATCC employee opening a biorepository tank

Biorepository Services^SM

We’ll take care of the logistics and resources needed to keep your COVID-19 materials safe, so you can focus on what’s important—your research.

Custom Controls & Derivatives

We can design and produce external controls and derivatives in a variety of formats to help you verify, validate, and/or routinely monitor the performance of your workflow and assay.

ABRF-MGRG Metagenomics Reference Standards

Mock microbial communities developed and packaged as part of the Extreme Microbiome Project (XMP), comprised of long-fragment gDNA from Class I microbial genomes, and confirmed to be free of human DNA

Microbiome Reference Standards

ATCC^® Microbiome Standards are the only reference materials on the market completely manufactured from high-quality ATCC Genuine Cultures^® that are characterized by polyphasic testing, fully sequenced, and published in various databases.

Exosomes

ATCC offers exosomes derived from well-authenticated cell lines and hTERT-immortalized mesenchymal stem cells. These extracellular vesicles can be used as standards for diagnostics development, disease marker studies, and vaccine development.